PACS Stock Overview
Through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
PACS Group, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$17.10 |
| 52 Week High | US$43.92 |
| 52 Week Low | US$16.58 |
| Beta | 0 |
| 11 Month Change | -58.06% |
| 3 Month Change | -57.28% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -25.65% |
Recent News & Updates
Shareholder Returns
| PACS | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -16.5% | -4.6% | -1.2% |
| 1Y | n/a | 1.1% | 30.4% |
Return vs Industry: Insufficient data to determine how PACS performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how PACS performed against the US Market.
Price Volatility
| PACS volatility | |
|---|---|
| PACS Average Weekly Movement | 14.8% |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: PACS's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: PACS's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 32,433 | Jason Murray | pacs.com |
PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties.
PACS Group, Inc. Fundamentals Summary
| PACS fundamental statistics | |
|---|---|
| Market cap | US$2.65b |
| Earnings (TTM) | US$92.29m |
| Revenue (TTM) | US$3.56b |
28.8x
P/E Ratio0.7x
P/S RatioIs PACS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PACS income statement (TTM) | |
|---|---|
| Revenue | US$3.56b |
| Cost of Revenue | US$3.04b |
| Gross Profit | US$519.14m |
| Other Expenses | US$426.86m |
| Earnings | US$92.29m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.59 |
| Gross Margin | 14.59% |
| Net Profit Margin | 2.59% |
| Debt/Equity Ratio | 84.9% |
How did PACS perform over the long term?
See historical performance and comparison